Dexcom Inc
NASDAQ:DXCM
Dexcom Inc
Depreciation & Amortization
Dexcom Inc
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dexcom Inc
NASDAQ:DXCM
|
Depreciation & Amortization
-$8.1m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Boston Scientific Corp
NYSE:BSX
|
Depreciation & Amortization
-$828m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
Stryker Corp
NYSE:SYK
|
Depreciation & Amortization
-$635m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-16%
|
|
Abbott Laboratories
NYSE:ABT
|
Depreciation & Amortization
-$1.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-14%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Depreciation & Amortization
-$3.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Dexcom Inc's Depreciation & Amortization?
Depreciation & Amortization
-8.1m
USD
Based on the financial report for Dec 31, 2023, Dexcom Inc's Depreciation & Amortization amounts to -8.1m USD.
What is Dexcom Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 3Y
-48%
Over the last year, the Depreciation & Amortization growth was -8%. The average annual Depreciation & Amortization growth rates for Dexcom Inc have been -48% over the past three years .